Uroplasty, Inc. (Amex: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.
Both Uroplasty's Urgent® PC and Macroplastique® were highlighted. Urgent® PC presentations and posters included:
- "Six and 12 Month Results from OrBIT Trial Comparing Percutaneous Tibial Nerve Stimulation (PTNS) vs. Extended-Release Tolterodine," a poster presentation by Kenneth M. Peters, M.D., Chairman of the Department of Urology at Beaumont Hospital in Royal Oak, Mich., demonstrated Urgent® PC has comparable performance to the leading prescribed overactive bladder drug and excellent durability through 12 months of follow-up. To assess the longer term effectiveness of Urgent PC, 30 and 25 patients in the OrBIT study completed voiding diaries at 6 and 12 months respectively. The patients showed sustained improvement with self-assessment of 93.8 percent improvement at 6 months and 96 percent at 12 months. Investigators' assessments of improvement were similar, 96.9 percent and 96 percent. There were no serious adverse events or device malfunctions.
- "Percutaneous Tibial Nerve Stimulation: Efficacy with Patients also Taking Anticholinergics," a poster presented by Leslie Wooldridge, GNP, of Mercy Health Partners Bladder Control Clinic, Muskegon, Mich., found Urgent PC to be an effective adjunct to anticholinergic medications or replacement for medications used to treat overactive bladder symptoms.
- "Is Cost the Achilles Heel of Posterior Tibial Nerve Stimulation? A Cost Minimisation Comparison with Antimuscarinic Therapy in the Management of OAB," a poster presented by Dudley Robinson, M.D., of King's College Hospital in London, England, suggesting that while drug therapy is initially less expensive than Urgent PC, there is a trend to reduced costs in Urgent PC over time as the initial equipment costs are offset, suggesting that therapy may become increasingly cost effective over the long term.
Urgent PC was highlighted in workshops entitled: